Alicja R. Rudnicka, PhD, Christopher G. Owen, PhD and David P. Strachan, MD
|
|
- Toby Bell
- 7 years ago
- Views:
Transcription
1 Alicja R. Rudnicka, PhD, Christopher G. Owen, PhD and David P. Strachan, MD Division of Community Health Sciences, St George s, University of London, London, United Kingdom 19581wk mo 1mo44 45 / A1c D C von Willebrand 1mo / von Willebrand C 1mo 1mo (breastfeeding); (cardiovascular risk factors); (respiratory risk factors); (epidemiology) FEV 1 = forced expiratory volume in 1 second HbA1c = hemoglobin A1c t-pa = tissue plasminogen activator antigen Vwf = von Willebrand factor HDL = high-density lipoprotein cholesterol LDL = low-density lipoprotein cholesterol CRP = C-reactive protein CI = confidence interval Address correspondence to Alicja R. Rudnicka, PhD, Division of Community Health Sciences, St George s, University of London, Cranmer Terrace, London SW17 0RE, United Kingdom. arudnick@sgul.ac. uk PEDIATRICS
2 [1] [2] [35] (2 ) [68] [9] [10, 11] [12] [12] [13, 14] [15] [16, 17] wk (1958) (78%) ( 44 45) mo1mo [10, 13, 1721] (33) Leicester ( ) 0.1 kg BMI kg / mm 2 5min Omron 705CP (Omron) 3 ( ) 32 cm Vitalograph Micro ( Vitalograph Ltd)1 (FEV 1 ) 234 RUDNICKA et al
3 Sarstedt (Leicester) (HbA1c) (t-pa) von Willebrand (Vwf) (HDL) HDL (LDL) Clauss [22] (MDA 180 Biomerieux) D ELISA ( Hyphen) CRP (BN ProSpec Dade Behring) C(CRP) T-PA vwfelisa ( Biopool DAKO) (ref 01 / 1 / 44) / HDL HbA1c D CRP t-pa vwf log 1 a 1mo 1mo P b (s) / cm (9.1) (9.3) (9.4) (9.3) 0.02 BMI/kg m (5.1) 27.8 (5.2) 27.5 (5.0) 27.2 (5.0) / mm Hg (16.5) (16.4) (15.8) (16.9) 0.61 / mm Hg 78.9 (10.8) 79.1 (10.6) 78.4 (10.4) 78.8 (11.1) 0.61 / mmol L (1.05) 5.91 (1.09) 5.90 (1.11) 5.87 (1.09) 0.25 LDL / mmol L (0.92) 3.44 (0.90) 3.44 (0.92) 3.41 (0.90) 0.11 FEV 1 / L 3.25 (0.52) 3.28 (0.52) 3.29 (0.51) 3.30 (0.52) 0.09 (GSD) c / cm 91.0 (1.2) 91.6 (1.2) 90.9 (1.2) 90.2 (1.2) / cm (1.1) (1.1) (1.1) (1.1) 0.06 / 0.87 (1.11) 0.87 (1.10) 0.87 (1.10) 0.86 (1.10) HDL / mmol LL (1.28) 1.50 (1.28) 1.51 (1.28) 1.53 (1.28) / mmol L (1.85) 1.72 (1.81) 1.68 (1.81) 1.66 (1.82) 0.06 Hba1c / % 5.24 (1.11) 5.23 (1.11) 5.23 (1.12) 5.20 (1.10) 0.08 /g L (1.23) 2.94 (1.23) 2.90 (1.22) 2.87 (1.22) CRP / mg L (3.27) 1.10 (3.31) 1.08 (3.26) 0.96 (3.39) D /ng L (1.8) (1.8) (1.8) (1.8) 0.02 t-pa / ng L (1.75) 4.64 (1.73) 4.57 (1.57) 4.38 (1.74) vwf / IU L (1.1) (1.4) (1.4) (1.4) /% (BMI 30 kg m -2 ) a 7 b 3 P c GDS log s 95% ( GSD 2 ) ( GSS 2 ) PEDIATRICS
4 1 mo 1mo [23, 24] logistic (BMI 30 kg / m 2 ) log Stata 9.2 (Stata Corp College Station TX) (87%) 46% (n = 3 772) 1mo 24% (n = 1 960) 1 mo30% (n = 2 440) HDL BMI / D CRP t-pa vwf ( P = 0.06) (P =0.06)HbA1c (P =0.08) () LDLFEV 1 ( 1) 1mo ( 46%) ( ) ( 2) 1mo( 50% 40% 37%) 1mo42% (46%) ( 3) 1mo 0.81% 95% (CI) 1.47% 0.14%/ (0.54% 95% CI0.92% 0.16%) ( % CI ) (1.43% 95% CI 2.55% 0.30%) vwf (2.15% 95% CI4.01% 0.26%) t-pa (2.75% 95% CI 5.54% 0.11%) (P ) CRP ( P ) CRP 1mo 2.6% (95% CI 4.6% 1.0% P = 0.003) CRP 12.8% (95% CI 21.5% 3.0% P =0.01) / 236 RUDNICKA et al
5 2 / n (%) b 1 mo 1mo a 624 (52) (50) 945 (48) (50) 581 (48) (50) (50) (50) a 97 (8.1) 400 (16) 154 (7.9) 280 (7.4) 37 (3.1) 240 (9.8) 162 (8.3) 216 (5.7) 85 (7.0) 207 (8.5) 177 (9.0) 301 (8.0) 112 (9.3) 286 (1.2) 279 (14) 453 (12) 72 (6.0) 193 (7.9) 158 (8.1) 264 (7.0) 54 (4.5) 182 (7.5) 107 (5.5) 140 (3.7) 84 (7.0) 209 (8.6) 215 (11) 338 (9.0) 54 (4.5) 159 (6.5) 138 (7.0) 344 (9.1) 65 (5.4) 124 (5.1) 97 (5.0) 235 (6.2) 67 (5.6) 104 (4.3) 100 (5.1) 276 (7.3) 42 (3.5) 91 (3.7) 90 (4.6) 251 (6.6) 197 (16) 221 (9.1) 259 (13.2) 607 (16.1) 239 (20) 24 (1.0) 24 (1.2) 67 (1.8) a 69 (5.7) 91 (3.7) 76 (3.9) 242 (6.4) 116 (9.6) 311 (13) 233 (12) 634 (17) 90 (7.5) 210 (8.6) 169 (8.6) 442 (12) 433 (36) (50) (52) (47) 114 (9.5) 351 (14) 259 (13) 404 (11) 80 (6.6) 224 (9.2) 184 (9.4) 246 (6.5) 2 (0.2) 16 (0.7) 9 (0.5) 13 (0.3) 301 (25) 7 (0.3) 2 (0.1) 1 (0.03) a 603 (50) (60) (62) (70) 159 (13) 380 (16) 311 (16) 450 (12) 119 (9.9) 332 (14) 223 (11) 331 (8.8) 50 (4.2) 155 (6.4) 126 (6.4) 193 (5.1) 274 (23) 104 (4.3) 79 (4.0) 148 (3.9) /kg a (13) 362 (15) 310 (16) 463 (12) (45) (51) (54) (57) (18) 662 (27) 477 (24) 968 (26) (1.0) 39 (1.6) 23 (1.2) 30 (1.0) 287 (24) 131 (5.4) 96 (4.9) 172 (4.6) /kg a (21) 642 (26) 442 (23) 728 (19) (18) 516 (21) 492 (25) 860 (23) (15) 397 (16) 354 (18) 785 (21) (12) 433 (18) 352 (18) 678 (18) (9.7) 290 (12) 214 (11) 495 (13) PEDIATRICS
6 289 (24) 162 (6.6) 106 (5.4) 226 (6.0) (s) / kg 3.30 (0.53) 3.30 (0.57) 3.33 (0.49) 3.38 (0.48) a 77 (6.4) 91 (3.7) 81 (4.1) 243 (6.4) 417 (35) 791 (32) 643 (33) (38) 235 (20) 500 (20) 425 (22) 775 (21) 249 (21) 490 (20) 387 (20) 617 (16) 130 (11) 340 (14) 262 (13) 428 (11) 43 (3.6) 101 (4.1) 75 (3.8) 109 (2.9) 4 (0.3) 3 (0.1) 1 (0.1) 9 (0.2) 50 (4.2) 124 (5.1) 76 (3.9) 158 (4.2) a 519 (43) (45) 869 (44) (44) / 354(29) 643 (26) 544 (28) (31) 300 (25) 616 (25) 490 (25) 796 (21) 32 (2.7) 86 (3.5) 57 (2.9) 123 (3.3) / n a 10% b 7 ( ) ( ) CRP vwf 1mo 1.9% CRP13.6% 1 mo 1mo () vwf 2.0% 1.3% 1mo 1.9%CRP 13.6% 1mo BMI / LDL HbA1C t-pa vwf FEV 1 HDL 1 mo ( 0.8%) / ( 0.5%) ( 15%) ( 3%) CRP (13%)t-PA (3%) vwf ( 2%) 3 [10, 18, 25] BMI ( 238 RUDNICKA et al
7 BMI ) [19] BMI [10, 13, 25, 26] 1 mo (BMI 30 kg / m 2 ) 15% ( % CI ) [13] ( % CI ) [17] 1/3 (30%) 15% 4% [2731] [27] mo 1mo 1mo 1mo (95% CI) (95% CI) P a / cm ( ) 0.18 ( ) 0.28 BMI / kg m ( ) 0.22 ( ) 0.10 / mm Hg ( ) 0.30 ( ) 0.34 / mm Hg ( ) 0.15 ( ) 0.50 / mmol L ( ) 0.01 ( ) 0.60 LDL / mmol L ( ) 0.02 ( ) 0.37 FEV 1 / L ( ) 0.02 ( ) 0.15 (95% CI) a / cm ( ) 0.81 ( ) 0.01 / cm ( ) 0.31 ( ) 0.17 / ( ) 0.54 ( ) HDL / mmol L ( ) 0.56 ( ) 0.40 / mmol L ( ) 0.15 ( ) 0.94 Hba1c / % ( ) 0.05 ( ) 0.93 /g L ( ) 1.43 ( ) 0.01 D /ng L ( ) 2.81 ( ) 0.10 CRP / mg L ( ) 5.04 ( ) 0.12 t-pa / ng ml ( ) 2.75 ( ) 0.05 vwf / IU L ( ) 2.15 ( ) 0.04 (95% CI) (BMI 30 kg m -2 ) ( ) 0.85 ( ) 0.02 a () BMI / ( / ) ( LDL ( FEV 1 ( 24 h 3 wk () () / () HDL ( ) ( ) HbA1c ( ) CRP D ( ) t-pa Vwf ( ) PEDIATRICS
8 2.6 [27] 28% 2.5% [32] [4] () [25] [33] 2 ( % CI ) [33] HbA1c ( HbA1c 60 d ) [28, 3437] 1/41/5 30% 60% / [28, 30, 31, 38] / 21 [39] 10% 15% 1mo 1% 1 mo 2 [16,40] ( 1 000) 2 [41] [42,43] [25] 1mo [5] LDL0.2 mmol / L 3mo [44] [15] vwf t-pa CRP (P ) [25] ( 50 y) CRP [45] CRP [21] 240 RUDNICKA et al
9 vwf [4649] [5055] BMI / [27, 29, 31, 37] [39] (3%) 7y (46%) 1mo [56] ( 54% 1mo) 20 [57] [58] [59] 1958 (97%) 1mo / (1mo) 1 World Health Organization. The World Health Report 2002: Reducing Risks, Promoting Healthy Life. Geneva, Switzerland: World Health Organization; Lucas A. Programming by early nutrition in man. In: Bock GR, et al, eds. The Childhood Environment and Adult Disease. 1st ed. Chichester, United Kingdom: Wiley; 1991: Ravelli AC, et al. Arch Dis Child. 2000;82: Singhal A, et al. Lancet 2003;361: Owen CG, et al. Pediatrics 2002;110: Fall CH, et al. BMJ 1992;304: Pettitt DJ, et al. Lancet 1997;350: Young TK, et al. Arch Pediatr Adolesc Med 2002;156: Martin RM, et al. Eur Heart J 2004;25: Victora CG, et al. BMJ 2003;327: Martin RM, et al. Arch Dis Child Fetal Neonatal Ed 2002;87: F193 F von Kries R, et al. BMJ 1999;319: Parsons TJ, et al. Arch Dis Child 2003;88: Li L, et al. BMJ 2003;327: Shaukat A, et al. J Am Coll Nutr 2005;24: Owen CG, et al. BMJ 2003;327: Owen CG, et al. Pediatrics 2005;115: Wadsworth M, et al. BMJ 1999;319: Owen CG, et al. Am J Clin Nutr 2005;82: Martin RM, et al. Clin Endocrinol (Oxf) 2005;62: Williams MJ, et al. J Epidemiol Community Health 2006;60: PEDIATRICS
10 von Clauss A. Acta Haematol 1957;17: Marmot MG, et al. J Epidemiol Community Health 1980;34: Fall CH, et al. BMJ 1995;310: Martin RM, et al. J Epidemiol Community Health 2005;59: Gillman MW, et al. JAMA 2001;285: Shaper AG, et al. BMJ 1997;314: Rexrode KM, et al. Int J Obes Relat Metab Disord 2001;25: Whitlock G, et al. Semin Vasc Med 2002;2: Hu G, et al. Eur Heart J 2004;25: Yusuf S, et al. Lancet 2005;366: Stettler N, et al. Pediatrics 2002;109: Owen CG, et al. Am J Clin Nutr 2006;84: Chan JM, et al. Diabetes Care 1994;17: Ohlson LO, et al. Diabetes 1985;34: Lundgren H, et al. Int J Obes (Lond) 1989;13: Welborn TA, et al. Med J Aust 2003;179: Dagenais GR, et al. Am Heart J 2005;149: Snijder MB, et al. Am J Clin Nutr 2003;77: Martin RM, et al. Am J Epidemiol 2005;161: Taittonen L, et al. Pediatr Res 1996;40: Lawlor DA, et al. Arch Dis Child 2005;90: Martin RM, et al. Circulation 2004;109: Kolacek S, et al. Acta Paediatr 1993;82: Singhal A, et al. Lancet 2004;363: Whincup PH, et al. Eur Heart J 2002;23: Lowe GD, et al. Eur Heart J 2004;25: Danesh J, et al. N Engl J Med 2004;350: Fibrinogen Studies Collaboration. JAMA 2005;294: Lucas A, et al. Lancet 1992;339: Lanting CI, et al. Lancet 1994;344: Horwood LJ, et al. Pediatrics 1998;101(1). Available at: www. pediatrics.org/cgi/content/full/101/1/e9 53 Anderson JW, et al. Am J Clin Nutr 1999; 70: Vestergaard M, et al. Acta Paediatr 1999; 88: SanGiovanni JP, et al. Early Hum Dev 2000;57: Newson J, et al. Infant Care in an Urban Community. London, United Kingdom: George Allen and Unwin; Kark JD, et al. J Epidemiol Community Health 1984;38: Oppe TE. Present-Day Practice in Infant Feeding. Report of a working party of the Panel on Child Nutrition, Committee on Medical Aspects of Food Policy. London, United Kingdom: HMSO; Cockburn F, et al. Weaning and the Weaning Diet. Report of the Working Group on the Weaning Diet of the Committee on Medical Aspects of Food Policy Great Britain Department of Health. London, United Kingdom: Her Majesty s Stationery Office; 1994 PEDIATRICS 2007;119(5):e1107 e RUDNICKA et al
MY TYPE 2 DIABETES NUMBERS
BLOOD SUGAR MANAGEMENT GUIDE MY TYPE 2 DIABETES NUMBERS Understanding and Tracking the ABCs of Type 2 Diabetes 1 BLOOD MY TYPE SUGAR 2 DIABETES MANAGEMENT ABC NUMBERS GUIDE When you have type 2 diabetes,
More informationDietary Composition for Weight Loss and Weight Loss Maintenance
Dietary Composition for Weight Loss and Weight Loss Maintenance Bridget M. Hron, MD Instructor in Pediatrics, Harvard Medical School Staff Physician in Gastroenterology & Nutrition and New Balance Foundation
More informationAlbumin and All-Cause Mortality Risk in Insurance Applicants
Copyright E 2010 Journal of Insurance Medicine J Insur Med 2010;42:11 17 MORTALITY Albumin and All-Cause Mortality Risk in Insurance Applicants Michael Fulks, MD; Robert L. Stout, PhD; Vera F. Dolan, MSPH
More informationKrystal Revai, MD, FAAP. Written Testimony. Breastfeeding as Primary Obesity Prevention. Obesity Prevention Initiative Act Public Hearings
Written Testimony Breastfeeding as Primary Obesity Prevention Obesity Prevention Initiative Act Public Hearings on behalf of the ILLINOIS CHAPTER, AMERICAN ACADEMY OF PEDIATRICS Submitted March 15, 2010
More informationDose-Response Effects of Sodium Intake on Blood Pressure
I Dose-Response Effects of Sodium Intake on 1 +2 NS +1 NS -2 NS +5 NS 0.46 (20) 4.6 () 25.9 (1128) FIGURE I-1 Blood pressure (mm Hg) according to dietary sodium intake in g/d (mmol/d) among 8 normotensive
More informationMetabolic Syndrome Overview: Easy Living, Bitter Harvest. Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007
Metabolic Syndrome Overview: Easy Living, Bitter Harvest Sabrina Gill MD MPH FRCPC Caroline Stigant MD FRCPC BC Nephrology Days, October 2007 Evolution of Metabolic Syndrome 1923: Kylin describes clustering
More informationThe Influence of Infant Health on Adult Chronic Disease
The Influence of Infant Health on Adult Chronic Disease Womb to Tomb Dr Clare MacVicar Introduction Many diseases in adulthood are related to growth patterns during early life Maternal nutrition important
More informationObjectives. What is undernutrition? What is undernutrition? What does undernutrition look like?
Objectives Basics Jean-Pierre Habicht, MD, PhD Professor Division of Nutritional Sciences Cornell University Types and causes Determinants Consequences Global occurrence and progress Way forward What is
More informationMultiple comorbidities: additive and predictive of cardiovascular risk. Peter M. Nilsson Lund University University Hospital Malmö, Sweden
Multiple comorbidities: additive and predictive of cardiovascular risk Peter M. Nilsson Lund University University Hospital Malmö, Sweden Clinical outcomes: major complications of CVD Heart Attack/ACS
More informationPrevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012
Prevention of and the Screening for Diabetes Part I Insulin Resistance By James L. Holly, MD Your Life Your Health The Examiner January 19, 2012 In 2002, SETMA began a relationship with Joslin Diabetes
More informationESCMID Online Lecture Library. by author
Do statins improve outcomes of patients with sepsis and pneumonia? Jordi Carratalà Department of Infectious Diseases Statins for sepsis & community-acquired pneumonia Sepsis and CAP are major healthcare
More informationINSULIN RESISTANCE AND COMPENSATORY HYPERINSULINEMIA: THE LINCHPIN BETWEEN OBESITY AND CARDIOVASCULAR DISEASE
May 2008 (Vol. 1, Issue 2, pages 4-10) INSULIN RESISTANCE AND COMPENSATORY HYPERINSULINEMIA: THE LINCHPIN BETWEEN OBESITY AND CARDIOVASCULAR DISEASE By Gerald M. Reaven, MD, Division of Cardiovascular
More informationVitamin D in Infancy, Childhood and Adolescence
Vitamin D in Infancy, Childhood and Adolescence Christopher Kovacs, MD, FRCPC, FACP Professor of Medicine (Endocrinology) Memorial University of Newfoundland ckovacs@mun.ca Disclosure I am currently serving
More informationCardiovascular disease physiology. Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011
Cardiovascular disease physiology Linda Lowe-Krentz Bioscience in the 21 st Century October 14, 2011 Content Introduction The number 1 killer in America Some statistics Recommendations The disease process
More informationBreast-feeding and brain development
ænutrition and the brain Breast-feeding and brain development Kim Fleischer Michaelsen 1, Lotte Lauritzen 1, Marianne Hørby Jørgensen 2 and Erik Lykke Mortensen 3,4 1 Department of Human Nutrition, The
More informationThe Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery
The Link Between Obesity and Diabetes The Rapid Evolution and Positive Results of Bariatric Surgery Michael E. Farkouh, MD, MSc Peter Munk Chair in Multinational Clinical Trials Director, Heart and Stroke
More informationProtein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075
Title: Protein Intake in Potentially Insulin Resistant Adults: Impact on Glycemic and Lipoprotein Profiles - NPB #01-075 Investigator: Institution: Gail Gates, PhD, RD/LD Oklahoma State University Date
More informationObesity and Socioeconomic Status in Children and Adolescents: United States, 2005 2008
Obesity and Socioeconomic Status in Children and Adolescents: United States, 2005 2008 Cynthia L. Ogden, Ph.D.; Molly M. Lamb, Ph.D.; Margaret D. Carroll, M.S.P.H.; and Katherine M. Flegal, Ph.D. Key findings
More informationYOUR GUIDE TO. Managing and Understanding Your Cholesterol Levels
YOUR GUIDE TO Managing and Understanding Your Cholesterol Levels Our goal at the Mercy Health Heart Institute is to help you be well. Our experienced team includes cardiologists, cardiovascular surgeons,
More information1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME
1. PATHOPHYSIOLOGY OF METABOLIC SYNDROME Izet Aganović, Tina Dušek Department of Internal Medicine, Division of Endocrinology, University Hospital Center Zagreb, Croatia 1 Introduction The metabolic syndrome
More informationPrevalence of Diabetic Retinopathy: A Pilot Study from the SEARCH for Diabetes in Youth Study
Prevalence of Diabetic Retinopathy: A Pilot Study from the SEARCH for Diabetes in Youth Study Elizabeth J Mayer-Davis, PhD University of North Carolina at Chapel Hill For the SEARCH Study Group, May 2014
More informationNutrition for Family Living
Susan Nitzke, Nutrition Specialist; susan.nitzke@ces.uwex.edu Sherry Tanumihardjo, Nutrition Specialist; sherry.tan@ces.uwex.edu Amy Rettammel, Outreach Specialist; arettamm@facstaff.wisc.edu Betsy Kelley,
More informationAppendix: Description of the DIETRON model
Appendix: Description of the DIETRON model Much of the description of the DIETRON model that appears in this appendix is taken from an earlier publication outlining the development of the model (Scarborough
More informationHEALTH BENEFITS. Omega-3 Fish Oil
HEALTH BENEFITS Omega-3 Fish Oil Omega-3 fatty acids are essential polyunsaturated fats. They cannot be manufactured by the body and therefore must be consumed through food or supplements. Three types
More informationThe WHI 12 Years Later: What Have We Learned about Postmenopausal HRT?
AACE 23 rd Annual Scientific and Clinical Congress (2014) Syllabus Materials: The WHI 12 Years Later: What Have We Learned about Postmenopausal HRT? JoAnn E. Manson, MD, DrPH, FACP, FACE Chief, Division
More informationNutrition Requirements
Who is responsible for setting nutrition requirements in the UK? In the UK we have a set of Dietary Reference Values (DRVs). DRVs are a series of estimates of the energy and nutritional requirements of
More informationComplicanze del diabete nel bambino e nell adolescente
Clinica Pediatrica Università di Chieti Complicanze del diabete nel bambino e nell adolescente Franco Chiarelli XVII Congresso Nazionale SIPPS Parma, 25 Novembre 2005 Type 1 diabetes in childhood: Only
More informationIsabella Sudano & Franco Muggli
Swiss Hypertension Guidelines Isabella Sudano & Franco Muggli CoLaus, Swisshype ESC 2005 Dokumentenname Datum Seite 1 European Journal of Cardiovascular Prevention and Rehabilitation 2009 Guideline...
More informationDiagnosis, classification and prevention of diabetes
Diagnosis, classification and prevention of diabetes Section 1 1 of 4 Curriculum Module II 1 Diagnosis, classification and presentation of diabetes Slide 2 of 48 Polyurea Definition of diabetes Slide 3
More informationMen Sexual Dysfunction Associated with Obesity and Metabolic Syndrome
Men Sexual Dysfunction Associated with Obesity and Metabolic Syndrome By Aly A. Abbassy, MD, FACE Professor of Medicine (Endocrinology) Alexandria University My Talk will include: 1-Types of Men sexual
More informationLong term Weight Management in Obese Diabetic Patients Osama Hamdy, MD, PhD, FACE
Long term Weight Management in Obese Diabetic Patients Osama Hamdy, MD, PhD, FACE Medical Director, Obesity Clinical Program, Director of Inpatient Diabetes Management, Joslin Diabetes Center Assistant
More informationC-Reactive Protein and Diabetes: proving a negative, for a change?
C-Reactive Protein and Diabetes: proving a negative, for a change? Eric Brunner PhD FFPH Reader in Epidemiology and Public Health MRC Centre for Causal Analyses in Translational Epidemiology 2 March 2009
More informationGetting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research?
Getting Off the Chronic Disease Merry-Go-Round: What s the Weight of the Research? Jody Dushay, MD MMSc Beth Israel Deaconess Medical Center Boston, MA Session 445 No disclosures Disclosure Jody Dushay,
More informationCardiovascular Disease in Diabetes
Cardiovascular Disease in Diabetes Where Do We Stand in 2012? David M. Kendall, MD Distinguished Medical Fellow Lilly Diabetes Associate Professor of Medicine University of MInnesota Disclosure - Duality
More informationFreiburg Study. The other 24 subjects had healthy markers closer to what would be considered ideal.
Freiburg Study The Freiburg Study was conducted with 48 healthy human subjects of various ages. None of the test subjects had been diagnosed with any disease prior to the study. None were taking any type
More informationBody Composition & Longevity. Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ
Body Composition & Longevity Ohan Karatoprak, MD, AAFP Clinical Assistant Professor, UMDNJ LONGEVITY Genetic 25% Environmental Lifestyle Stress 75% BMI >30 OBESE 25-30 OVERWEIGHT 18-25 NORMAL WEIGHT 18
More informationMississippi Delta Health Collaborative Mississippi State Department of Health 1
The Impact of Community Health Workers on Cardiovascular Risk Reduction : Findings from the Clinical Community Health Worker Initiative Mississippi Delta Health Collaborative Mississippi State Department
More informationPCORI Methodology Standards: Academic Curriculum. 2016 Patient-Centered Outcomes Research Institute. All Rights Reserved.
PCORI Methodology Standards: Academic Curriculum 2016 Patient-Centered Outcomes Research Institute. All Rights Reserved. Module 9: Putting it All Together: Appraising a Systematic Review Category 11: Systematic
More informationJill Malcolm, Karen Moir
Evaluation of Fife- DICE: Type 2 diabetes insulin conversion Article points 1. Fife-DICE is an insulin conversion group education programme. 2. People with greater than 7.5% on maximum oral therapy are
More informationLDL PARTICLE SIZE: DOES IT MATTER? Samia Mora, M.D., M.H.S., Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts.
LDL PARTICLE SIZE: DOES IT MATTER? Samia Mora, M.D., M.H.S., Brigham and Women s Hospital, Harvard Medical School, Boston, Massachusetts Introduction While both small and large LDL particles may be atherogenic,
More informationHeart Disease, Stroke and Research Statistics At-a-Glance
Heart Disease, Stroke and Research Statistics At-a-Glance Here are a few key statistics about heart disease, stroke, other cardiovascular diseases and their risk factors, in addition to commonly cited
More informationT he first Whitehall study of British civil servants, begun in
922 RESEARCH REPORT Change in health inequalities among British civil servants: the Whitehall II study J E Ferrie, M J Shipley, G Davey Smith, S A Stansfeld, M G Marmot... J Epidemiol Community Health
More informationDIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE
DIET AND EXERCISE STRATEGIES FOR WEIGHT LOSS AND WEIGHT MAINTENANCE 40 yo woman, BMI 36. Motivated to begin diet therapy. Which of the following is contraindicated: Robert B. Baron MD MS Professor and
More informationRecommendations for Prescribing Exercise to Overweight and Obese Patients
10 Recommendations for Prescribing Exercise to Overweight and Obese Patients 10 10 Recommendations for Prescribing Exercise to Overweight and Obese Patients Effects of Exercise The increasing prevalence
More informationCoordinator of the Brazilian Institute of Health Technology Assessment Coordinator, Hypertension Unit, Division of Cardiology
FLÁVIO DANNI FUCHS Current Administrative and Academic Appointments Administrative Academic Coordinator of the Brazilian Institute of Health Technology Assessment Coordinator, Hypertension Unit, Division
More information25-hydroxyvitamin D: from bone and mineral to general health marker
DIABETES 25 OH Vitamin D TOTAL Assay 25-hydroxyvitamin D: from bone and mineral to general health marker FOR OUTSIDE THE US AND CANADA ONLY Vitamin D Receptors Brain Heart Breast Colon Pancreas Prostate
More informationRefeeding syndrome in anorexia nervosa
ESPEN Congress Barcelona 2012 Is there a role for nutrition in psychiatric disorders? Refeeding syndrome in anorexia nervosa V. Haas (Germany) ESPEN - 2012 - Barcelona The refeeding syndrome in Anorexia
More informationOverweight and Obesity in Nevada. Overweight and Obesity in Nevada. Public Health Issue. Overview. Background BRFSS. Objective 9/5/2013
Overweight and Obesity in Nevada Overweight and Obesity in Nevada A Comparison of Behavioral Risk Factor Surveillance System and Department of Motor Vehicles Data Department of Health and Human Services
More informationImplementing WHO Growth Charts in Canada an inter-professional collaboration led by dietitians
General information Symposiums can take up to two hours ant will offer a strong scientific focus and approach. They Workshops can take up to two hours and will have a practical, professional and hands
More informationPsoriasis Co-morbidities: Changing Clinical Practice. Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology. Psoriatic Arthritis
Psoriasis Co-morbidities: Changing Clinical Practice Theresa Schroeder Devere, MD Assistant Professor, OHSU Dermatology Psoriatic Arthritis Psoriatic Arthritis! 11-31% of patients with psoriasis have psoriatic
More informationVictims Compensation Claim Status of All Pending Claims and Claims Decided Within the Last Three Years
Claim#:021914-174 Initials: J.T. Last4SSN: 6996 DOB: 5/3/1970 Crime Date: 4/30/2013 Status: Claim is currently under review. Decision expected within 7 days Claim#:041715-334 Initials: M.S. Last4SSN: 2957
More informationRisk Factors for Fire Fighter Cardiovascular Disease
Risk Factors for Fire Fighter Cardiovascular Disease EXECUTIVE SUMMARY Prepared by: Jefferey L. Burgess, MD, MS, MPH Mel and Enid Zuckerman College of Public Health The University of Arizona The Fire Protection
More informationIs the Apparent Cardioprotective Effect of Recent Alcohol Consumption Due to Confounding by Prodromal Symptoms?
American Journal of Epidemiology Copyright 2000 by The Johns Hopkfns University School of Hygiene and Public Health Allrightsreserved Vol. 151, No. 12 Printed In USA. Is the Apparent Cardioprotective Effect
More informationInfant Feeding Practice and its effect on the Growth and Development of babies
Infant Feeding Practice and its effect on the Growth and Development of babies Author(s): B. Selvakumar, B. Vishnu Bhat Vol. 11, No. 1 (2007-10 - 2007-12) Curr Pediatr Res 2007; 11(1& 2): 13-16 B. Selvakumar,
More informationDIABETES YOUR GUIDE TO
YOUR GUIDE TO DIABETES b What is diabetes? b Type 2 diabetes prevention b Prevention checklist b Living with diabetes b Complications b Terms to know b Resources To promote and protect the health of Canadians
More informationAn Overview and Guide to Healthy Living with Type 2 Diabetes
MEETING YOUR GOALS An Overview and Guide to Healthy Living with Type 2 Diabetes MEETING YOUR GOALS This brochure was designed to help you understand the health goals to live a healthy lifestyle with type
More informationORIGINAL INVESTIGATION. Identifying Patients for Weight-Loss Treatment
Identifying Patients for Weight-Loss Treatment An Empirical Evaluation of the NHLBI Obesity Education Initiative Expert Panel Treatment Recommendations Michaela Kiernan, PhD; Marilyn A. Winkleby, PhD ORIGINAL
More informationYour healthcare provider has ordered a Boston Heart Cardiac Risk Assessment
Your healthcare provider has ordered a Boston Heart Cardiac Risk Assessment What does that mean for you? Your healthcare provider has determined that you may be at risk for cardiovascular disease (CVD).
More informationBarriers to Healthcare Services for People with Mental Disorders. Cardiovascular disorders and diabetes in people with severe mental illness
Barriers to Healthcare Services for People with Mental Disorders Cardiovascular disorders and diabetes in people with severe mental illness Dr. med. J. Cordes LVR- Klinikum Düsseldorf Kliniken der Heinrich-Heine-Universität
More informationResearch Prioritization Topic Brief. Topic 3: Care coordination in primary care
Research Prioritization Topic Brief Topic 3: Care coordination in primary care Compare the effectiveness of enhanced care coordination, including multicultural approaches, on improving the healthcare process
More informationAssessment of Hemoglobin Level of Pregnant Women Before and After Iron Deficiency Treatment Using Nonparametric Statistics
Assessment of Hemoglobin Level of Pregnant Women Before and After Iron Deficiency Treatment Using Nonparametric Statistics M. Abdollahian *, S. Ahmad *, S. Nuryani #, + D. Anggraini * School of Mathematical
More informationMeasuring the Effect of an Inpatient Amputee Rehabilitation Program on the Control of Diabetes Mellitus
Measuring the Effect of an Inpatient Amputee Rehabilitation Program on the Control of Diabetes Mellitus Dr. Sharon Grad 1, Dr. Tania Henriques 2, & Ashi Jain 3 1 Hamilton Health Science Physiatry, Ontario,
More informationA8b. Resuscitation of a Term Infant with Meconium Staining. Session Summary. Session Objectives. References
A8b Resuscitation of a Term Infant with Meconium Staining Karen Wright, PhD, NNP-BC Assistant Professor and Coordinator, Neonatal Nurse Practitioner Program Dept. of Women, Children, and Family Nursing,
More informationRole of Body Weight Reduction in Obesity-Associated Co-Morbidities
Obesity Role of Body Weight Reduction in JMAJ 48(1): 47 1, 2 Hideaki BUJO Professor, Department of Genome Research and Clinical Application (M6) Graduate School of Medicine, Chiba University Abstract:
More informationTreating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group. Learning Objectives. Background. CAPA 2015 Annual Conference
Treating Patients with PRE-DIABETES David Doriguzzi, PA-C First Valley Medical Group Learning Objectives To accurately make the diagnosis of pre-diabetes/metabolic syndrome To understand the prevalence
More informationHow To Know If You Have Microalbuminuria
3 PREVALENCE AND PREDICTORS OF MICROALBUMINURIA IN PATIENTS WITH TYPE 2 DIABETES MELLITUS: A CROSS-SECTIONAL OBSERVATIONAL STUDY Dr Ashok S Goswami *, Dr Janardan V Bhatt**; Dr Hitesh Patel *** *Associate
More informationKeeping Track of Your Health
Your Health Journal Keeping Track of Your Health Your Health Journal THE BASICS Name: Height: Weight: Date of birth: Primary doctor: Specialist: Specialist: Specialist: Specialist: Pharmacy: Health insurance:
More informationFSHN 370: Nutrition Throughout the Lifespan in Spain and U.S. Applying for an O Oral Communication designation Spring 2016
FSHN 370: Nutrition Throughout the Lifespan in Spain and U.S. Applying for an O Oral Communication designation Spring 2016 Spring 2016 3 credits Instructor: Anne C. Shovic, Ph.D., R.D. e-mail: shovic@hawaii.edu
More informationPantesin Effective support for heart healthy cholesterol levels*
Pantesin Effective support for heart healthy cholesterol levels* { Pantesin Effective support for heart healthy cholesterol levels* Many health-conscious adults keeping a watchful eye on their cholesterol
More informationE. OZCEYLAN /International Journal of Lean Thinking Volume 1, Issue 1 (June 2010)
I J L T k gv m1 I 1( J 2 0 1 0 ) LT k g. jmg: www. k g.m/ j AD S S m C m T M L g E Öz S ç ku D m I E g g C m 4 2 0 3 1 K T k z @ k.. ABSTRACT KEYWORDS L g m g m T m m m M m k g m m g g. F m T A m m x m
More informationNEWBORN (birth to 24 hours)
NEWBORN (birth to 24 hours) 3kg ETT size: 3mm ETT length: 14cm AIRTRAQ: GREY LMA size: 1 or 1.5 IGT size: 5 FG SHOCK: 15 joules CPR: one third of chest depth rate 100/min 3:1 The emphases in resuscitation
More informationContra Cost Health Plan Quality Program Summary November, 2013
Contra Cost Health Plan Quality Program Summary November, 2013 Mission Statement: Contra Costa Health Plan, along with our community and county health care providers, is committed to ensure our diverse
More informationObesity in the United States Workforce. Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000
P F I Z E R F A C T S Obesity in the United States Workforce Findings from the National Health and Nutrition Examination Surveys (NHANES) III and 1999-2000 p p Obesity in The United States Workforce One
More informationImproving cardiometabolic health in Major Mental Illness
Improving cardiometabolic health in Major Mental Illness Dr. Adrian Heald Consultant in Endocrinology and Diabetes Leighton Hospital, Crewe and Macclesfield Research Fellow, Manchester University Metabolic
More informationHoeveel zitten we en is dat erg?
Hoeveel zitten we en is dat erg? Hidde van der Ploeg Department of Public & Occupational Health EMGO Institute for Health & Care Research VU University Medical Centre Amsterdam London bus drivers & conductors
More informationAntioxidants and Heart Disease
Antioxidants and Heart Disease Antioxidants help protect every cell and membrane in the body against the ravages of everyday living, and thus may help prevent diseases that result from accumulated damage
More informationDIABETES CARE. Advice. Blood Pressure. Cholesterol. Diabetes control. Eyes. Feet. Guardian Drugs
DIABETES CARE What happens if you follow the Alphabet Strategy? As patients reach their targets, the chances of developing serious complications of diabetes will be reduced! 1 Stroke Eye disease Heart
More informationDet metaboliske Syndrom Hvad er risikoen hos patienter? Hvad gør NIP skizofreni på området?
Det metaboliske Syndrom Hvad er risikoen hos patienter? Hvad gør NIP skizofreni på området? Henrik Lublin Centerchef, dr.med. Psykiatrisk Center Glostrup Increased Mortality Rates for Medical Disorders
More informationTHE UNIVERSITY OF HONG KONG
THE UNIVERSITY OF HONG KONG School of N ursing 4/F William M W Mong Block 21 Sassoon Road, Pokfulam, Hong Kong Head of School: Professor Agnes Tiwari TEL : (852) 2819 2600 DN (London); MSc (Surrey); PhD
More informationRacial and ethnic disparities in type 2 diabetes
Racial and ethnic disparities in type 2 diabetes Nisa M. Maruthur, MD, MHS Assistant Professor of Medicine & Epidemiology Welch Center for Prevention, Epidemiology, & Clinical Research The Johns Hopkins
More informationSTUDY DESCRIPTION Background information, study purpose and study rationale
Sylvana M. Hidalgo, MD Originating Department: Pediatric Cardiology Submitting to: Medical Center Title: Single-Center Description of Clinical Presentation of Pulmonary Hypertension in Patients Also Diagnosed
More informationESPEN Congress Brussels 2005
ESPEN Congress Brussels 2005 Low carbohydrate or low fat diet to loose weight: Pro Low Fat Diets Arne Astrup 27th ESPEN Congress 28 August 2005 Low carbohydrate or low fat diet to loose weight: Pro Low
More informationA Calorie is a Calorie Or is It? 6 th Biennial Childhood Obesity Conference, June 30, 2011
A Calorie is a Calorie Or is It? 6 th Biennial Childhood Obesity Conference, June 30, 2011 Jeff S. Volek, Ph.D., R.D. Human Performance Laboratory Department of Kinesiology University of Connecticut Storrs,
More informationChickenpox and Shingles Vaccines
Chickenpox and Shingles Vaccines The chicken pox/shingles connection DISCLAIMER: The following is not intended as advice on whether or not to receive a chicken pox, shingles, or any other vaccine. The
More informationA Problem-Based Learning Approach to Incorporating Nutrition into the Medical Curriculum
A Problem-Based Learning Approach to Incorporating Nutrition into the Medical Curriculum Marilyn S. Edwards, Ph.D., R.D. * and Gary C. Rosenfeld, Ph.D. * Department of Internal Medicine and Department
More informationMortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies 1 3
Mortality in vegetarians and nonvegetarians: detailed findings from a collaborative analysis of 5 prospective studies 1 3 Timothy J Key, Gary E Fraser, Margaret Thorogood, Paul N Appleby, Valerie Beral,
More informationCardiology Department and Center for Research and Prevention of Atherosclerosis, Hadassah Hebrew University Medical Center.
CETP and IRS1 Genetic Variation Modulates Effects of Weight loss Diets on Lipid Profile in Two Independent 2 Year Diet Intervention Studies: The Pounds Lost and DIRECT Trails Ronen Durst, MD Cardiology
More informationLow diabetes numeracy predicts worse glycemic control
Low diabetes numeracy predicts worse glycemic control Kerri L. Cavanaugh, MD MHS, Kenneth A. Wallston, PhD, Tebeb Gebretsadik, MPH, Ayumi Shintani, PhD, MPH, Darren DeWalt, MD MPH, Michael Pignone, MD
More informationPrescription Cholesterol-lowering Medication Use in Adults Aged 40 and Over: United States, 2003 2012
NCHS Data Brief No. 77 December 4 Prescription Cholesterol-lowering Medication Use in Adults Aged 4 and Over: United States, 3 2 Qiuping Gu, M.D., Ph.D.; Ryne Paulose-Ram, Ph.D., M.A.; Vicki L. Burt, Sc.M.,
More informationA 4-year evaluation of blood pressure management in Trinidad and Tobago
Journal of Human Hypertension (1999) 13, 455 459 1999 Stockton Press. All rights reserved 0950-9240/99 $12.00 http://www.stockton-press.co.uk/jhh ORIGINAL ARTICLE A 4-year evaluation of blood pressure
More informationHealth Maintenance: Controlling Cholesterol
Sacramento Heart & Vascular Medical Associates February 18, 2012 500 University Ave. Sacramento, CA 95825 Page 1 What is cholesterol? Cholesterol is a fatty substance. It has both good and bad effects
More information嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯
The Clinical Efficacy and Safety of Sodium Glucose Cotransporter-2 (SGLT2) Inhibitors in Adults with Type 2 Diabetes Mellitus 嘉 義 長 庚 醫 院 藥 劑 科 Speaker : 翁 玟 雯 Diabetes Mellitus : A group of diseases characterized
More informationLong-term survival of children with cerebral palsy in Okinawa, Japan
DEVELOPMENTAL MEDICINE & CHILD NEUROLOGY ORIGINAL ARTICLE Long-term survival of children with cerebral palsy in Okinawa, Japan MAYUMI TOUYAMA 1 JUN TOUYAMA 1 YASUO OCHIAI 2 SATOSHI TOYOKAWA 3 YASUKI KOBAYASHI
More informationClinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D.
Clinical Research on Lifestyle Interventions to Treat Obesity and Asthma in Primary Care Jun Ma, M.D., Ph.D. Associate Investigator Palo Alto Medical Foundation Research Institute Consulting Assistant
More informationWhether breastfeeding protects
Clinical Care/Nutrition/Education O R I G I N A L A R T I C L E Influence of Breastfeeding on Obesity and Type 2 Diabetes Risk Factors in Latino Youth With a Family History of Type 2 Diabetes JAIMIE N.
More informationThe Emergency Department. Fear of Malpractice and Defensive Medicine in the Emergency Department. ED-Based Malpractice Claims
Fear of Malpractice and in the Emergency Department Darren P. Mareiniss, MD, JD Instructor Department of Emergency Medicine University of Maryland School of Medicine The Emergency Department Emergency
More informationFACT SHEET N 394 UPDATED MAY 2015. Healthy diet
FACT SHEET N 394 UPDATED MAY 2015 Healthy diet KEY FACTS n A healthy diet helps protect against malnutrition in all its forms, as well as noncommunicable diseases (NCDs), including diabetes, heart disease,
More informationHow can nutrition education contribute to competency-based resident evaluation? 1 4
How can nutrition education contribute to competency-based resident evaluation? 1 4 Darwin Deen ABSTRACT The Curriculum Committee of the Nutrition Academic Award (NAA) has created a consensus document
More informationHealth and lifestyles of people aged 50 and over
NC457_Elsa Nurse leaflet A5_NC457_Elsa Nurse leaflet A5 16/04/2012 16:18 Page 1 English Longitudinal Study of Ageing Health and lifestyles of people aged 50 and over This leaflet tells you more about the
More informationHow Do I Know The Pauling Therapy Is Working? And, How Long Will It Take?
How Do I Know The Pauling Therapy Is Working? And, How Long Will It Take? These are the 2 questions my customers ask most often. These are also the 2 questions that are the hardest to answer. So, I have
More information